Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis.
- DOI
- 10.1186/s13561-025-00668-x
- Published
- 2025 Sep 30
- Container
- Health economics review
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13561-025-00668-x,
title = {Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis.},
author = {Wang Y and Chen LC and Cheung KL and Steinke D and Gavan SP},
year = {2025},
journal = {Health economics review},
doi = {10.1186/s13561-025-00668-x},
url = {https://doi.org/10.1186/s13561-025-00668-x}
}RIS
TY - JOUR TI - Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis. AU - Wang Y AU - Chen LC AU - Cheung KL AU - Steinke D AU - Gavan SP PY - 2025 JO - Health economics review DO - 10.1186/s13561-025-00668-x UR - https://doi.org/10.1186/s13561-025-00668-x ER -
APA
Y, W., LC, C., KL, C., D, S., & SP, G. (2025). Primary endocrine therapy versus surgery plus endocrine therapy for early-stage breast cancer in older women without frailty: a cost-effectiveness and value of implementation analysis.. Health economics review. https://doi.org/10.1186/s13561-025-00668-x
Source records
- pubmed · retrieved 2026-09-26T18:04:26.216Z
- europe-pmc · retrieved 2026-09-26T18:04:26.240Z
- doaj · retrieved 2026-09-26T18:04:26.228Z